Found: 5
Select item for more details and to access through your institution.
Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real‐world multicenter cohort study.
- Published in:
- Hepatology Research, 2024, v. 54, n. 7, p. 627, doi. 10.1111/hepr.14021
- By:
- Publication type:
- Article
Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolizationeligible patients.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1081479
- By:
- Publication type:
- Article
Metabolic effects and cardiovascular disease risks of antiviral treatments in patients with chronic hepatitis B.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 7, p. 1, doi. 10.1002/jmv.29760
- By:
- Publication type:
- Article
Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study.
- Published in:
- Clinical & Molecular Hepatology, 2024, v. 30, n. 3, p. 500, doi. 10.3350/cmh.2024.0055
- By:
- Publication type:
- Article
Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 794, doi. 10.3350/cmh.2023.0057
- By:
- Publication type:
- Article